0001209191-24-000019.txt : 20240102 0001209191-24-000019.hdr.sgml : 20240102 20240102110921 ACCESSION NUMBER: 0001209191-24-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decker Lisa Lynn CENTRAL INDEX KEY: 0001783056 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 24500934 MAIL ADDRESS: STREET 1: C/O ATRECA INC. STREET 2: 500 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-28 0 0001117480 CHIMERIX INC CMRX 0001783056 Decker Lisa Lynn 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 1 0 0 0 0 Stock Option (Right to Buy) 0.92 2023-12-28 4 A 0 100000 0.00 A 2033-12-27 Common Stock 100000 100000 D One-third of the shares subject to the stock option will vest and become exercisable on December 28, 2024 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option is fully vested on December 28, 2026, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan). /s/ Michael Alrutz, Attorney-In-Fact 2023-12-30